Cargando…
In Silico Exploration of the Trypanothione Reductase (TryR) of L. mexicana
Human leishmaniasis is a neglected tropical disease which affects nearly 1.5 million people every year, with Mexico being an important endemic region. One of the major defense mechanisms of these parasites is based in the polyamine metabolic pathway, as it provides the necessary compounds for its su...
Autores principales: | Barrera-Téllez, Francisco J., Prieto-Martínez, Fernando D., Hernández-Campos, Alicia, Martínez-Mayorga, Karina, Castillo-Bocanegra, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671491/ https://www.ncbi.nlm.nih.gov/pubmed/38003236 http://dx.doi.org/10.3390/ijms242216046 |
Ejemplares similares
-
Leishmania mexicana Trypanothione Reductase Inhibitors: Computational and Biological Studies
por: Matadamas-Martínez, Félix, et al.
Publicado: (2019) -
Footprinting of Inhibitor Interactions of In Silico Identified Inhibitors of Trypanothione Reductase of Leishmania Parasite
por: Venkatesan, Santhosh K., et al.
Publicado: (2012) -
Trypanothione Reductase: A Target Protein for a Combined In Vitro and In Silico Screening Approach
por: Beig, Mathias, et al.
Publicado: (2015) -
Synthesis and Evaluation of Indatraline-Based Inhibitors for Trypanothione Reductase
por: Walton, Jeffrey G A, et al.
Publicado: (2011) -
Mini review on tricyclic compounds as an inhibitor of trypanothione reductase
por: Kumar, Suresh, et al.
Publicado: (2014)